SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-24-003537
Filing Date
2024-01-23
Accepted
2024-01-23 20:38:09
Documents
1
Period of Report
2024-01-23

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 10956
  Complete submission text file 0001140361-24-003537.txt   12346
Mailing Address C/O ULTRAGENYX PHARMACEUTICAL INC. 60 LEVERONI COURT NOVATO CA 94949
Business Address
Sharp Shalini (Reporting) CIK: 0001377202 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35921 | Film No.: 24554016

Mailing Address 3545 CRAY COURT SAN DIEGO CA 92121
Business Address 3545 CRAY COURT SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Issuer) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)